JPJohn Opeyemi Patrick

John Opeyemi Patrick

*This is an algorithmically generated author record based on publicly available information.

John Opeyemi Patrick has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Community-Based Healthcare Systems: A Strategic Lever for Achieving Health Equity and Universal Health Coverage

    by Evelyn Foster-Pagaebi, Kefas Paul Zawaya, Cephas Biya, Nneji Nmesomachukwu Eneda, Aliaa Mohammed Mahmoud Soliman, John Opeyemi Patrick

    Background: Health equity and universal health coverage are critical global health priorities, especially with regard to the 2030 Sustainable Development Goals. Yet, systemic obstacles exist, impeding billions from accessing essential healthcare services, particularly in low- and middle-income countries. Purpose of the Study: This study explores the pivotal role of community healthcare systems as the strategy for achieving health equity and universal health coverage, framed within social justice and primary healthcare principles. Methodology: A review and synthesis of global, regional and country specific evidences, along with policy frameworks and best practices was conducted using databases such as PubMed, Google Scholar, CINAHL, PsycINFO, Scopus, WHO and UNAIDS websites. The results were analyzed and only relevant and evidence-based studies were included in the study. Findings: Evidence from high-income, low-and middle-income countries underscore the crucial role community-based health systems play in providing accessible, culturally appropriate, and cost-efficient healthcare to communities around the world. Key barriers were identified. However, evidenced-based and innovative solutions exist. Policy recommendations emphasize recruitment, training and integration of community health workers into national health systems, inclusive financing, investment in digital infrastructure, and cross-sectoral collaborations. Conclusion: Effective community healthcare systems have resulted in significant increase in service use, and has bridged the health disparity gaps in local communities. This positions community healthcare as a strategic pivot to achieving health equity and sustainable health for all.


  • Biomarkers for Tuberculosis Diagnosis and Monitoring: A Review of Translational Progress

    by Olabisi Promise Lawal, Olufemi Adesola Adedayo, Sokoya Itunuoluwa Dorcas, Olukunle O. Akanbi, Bostock Chinecherem Okafor, Ikechukwu Kanu, Precious Esong Sone, John Opeyemi Patrick, Taiwo Oluwole Fabiyi, Bankole Israel Adeyemi, et al.

    Tuberculosis (TB) still presents a major threat to public health, and accurate diagnosis of tuberculosis, monitoring TB treatment, as well as TB drug resistance are still challenging goals. Research in biomarkers—both host, pathogen pathogen-derived—has led to novel frontiers in the diagnosis and management of TB. These advancements contribute to faster diagnosis, customized treatment plans, and better monitoring of response to therapy. Direct pathogen-based markers, such as M. tuberculosis DNA, lipoarabinomannan (LAM), and mycobacterial proteins, that directly demonstrate infection, have the most potential, particularly in resource-poor settings. Cytokines such as interferon-gamma (IFN-γ) and inflammatory markers, such as C-reactive protein (CRP), are endogenous biomarkers that mirror responses of the immune system and may play a role in the management of treatment, especially in immunocompromised populations, such as patients with HIV. These progresses notwithstanding, the application of a biomarker-centered approach on a large scale remains a major obstacle, due to technical, economic, and regulatory constraints. Furthermore, various performances among the biomarkers in different populations limit clinical utility. Future studies in this area should aim to create point-of-care diagnostics, multi-biomarker panels, and to integrate the device with digital health technology platforms for real-time monitoring. These methods have the potential to substantially improve TB control, particularly in low- and middle-income countries. If current challenges can be overcome and research horizons broadened, biomarker-driven diagnosis and monitoring strategies may have key contributions in global TB control.